Michael Drummond
Overview
Explore the profile of Michael Drummond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
5554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Espinosa O, Bejarano V, Franky I, Pagali S, Drummond M, Franco O
Sci Rep
. 2025 Jan;
15(1):918.
PMID: 39762274
This document determines the causes of mortality (2008-2022) and calculate per capita health expenditure (2013-2021) in octogenarians, nonagenarians and centenarians in the Colombian population, considering year, gender and age group....
2.
Espinosa O, Drummond M, Russo E, Williams D, Wix D
Int J Technol Assess Health Care
. 2025 Jan;
41(1):e3.
PMID: 39757736
A reflective analysis is presented on the potential added value that actuarial science can contribute to the field of health technology assessment. This topic is discussed based on the experience...
3.
Ardito V, Ciani O, Drummond M
Pharmacoeconomics
. 2024 Oct;
43(1):5-29.
PMID: 39405025
Background And Objective: In a context of growing clinical and financial uncertainty, pricing and payment schemes can act as possible solutions to the problems of affordability and access to health...
4.
Otte M, Dauben H, Ahn J, Gutierrez Ibarluzea I, Drummond M, Simoens S, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2024 Sep;
24(9):1061-1066.
PMID: 39221874
Introduction: This paper summarizes the results from a forum of healthcare experts, academia representatives, and public agency officials from emerging and established market countries on Value-Based Healthcare (VBHC) and Health...
5.
Ardito V, Cavallaro L, Drummond M, Ciani O
Pharmacoecon Open
. 2024 May;
8(5):765-772.
PMID: 38773050
Introduction: Innovative pricing and payment/reimbursement schemes have been proposed as one part of the solution to the problem of patient access to new health technologies or to the uncertainty about...
6.
Ghabri S, Dawoud D, Drummond M
Value Health
. 2024 Mar;
27(7):936-942.
PMID: 38548180
Objective: Inclusion of relevant effectiveness and safety outcomes in economic evaluation of health technologies is required to aid efficient healthcare decisions. Our objective was to identify the key issues related...
7.
Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, et al.
Appl Health Econ Health Policy
. 2023 Dec;
22(2):265-267.
PMID: 38141116
No abstract available.
8.
Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, et al.
Med Decis Making
. 2023 Dec;
44(2):127-128.
PMID: 38097383
No abstract available.
9.
Pichon-Riviere A, Drummond M, Palacios A, Garcia-Marti S, Augustovski F
Lancet Glob Health
. 2023 Sep;
11(10):e1510-e1511.
PMID: 37734791
No abstract available.
10.
Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, et al.
Value Health
. 2023 Jul;
26(10):1461-1473.
PMID: 37414276
Objectives: Although the ISPOR Value of Information (VOI) Task Force's reports outline VOI concepts and provide good-practice recommendations, there is no guidance for reporting VOI analyses. VOI analyses are usually...